In ₹ Crore except Per Share Latest Annual | HEALTHX FY26 | SURAKSHA FY26 | KRSNAA FY26 | NEPHROPLUS FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 824.32× | 52.78× | ◆ 18.00× | 88.35× | 52.78× +1462% | |
| P/B | ◆ 1.27× | 6.98× | 1.86× | 6.73× | 6.73× -81% | |
| EV/EBITDA | — | 17.79× | ◆ 11.01× | 32.18× | 17.79× | |
| Market Cap | ₹970 Cr | ₹1,699 Cr | ₹1,828 Cr | ₹7,517 Cr | ₹1,828 Cr -47% | |
| Growth | ||||||
| Revenue CAGR 3Y | 8.26% | — | ◆ 16.63% | — | 16.63% -50% | |
| Revenue CAGR 5Y | 19.20% | — | — | — | — | |
| Net Income CAGR 3Y | — | — | 17.76% | — | 17.76% | |
| Revenue YoY (latest Q) | ◆ 49.73% | 20.75% | 22.05% | — | 21.40% +132% | |
| Net Income YoY (latest Q) | -92.53% | ◆ 40.00% | -19.34% | — | 10.33% -996% | |
| Profitability | ||||||
| EBITDA Margin | -3.95% | ◆ 30.73% | 27.42% | 22.72% | 27.42% -114% | |
| Net Income Margin | -0.11% | 10.12% | ◆ 13.13% | 7.69% | 10.12% -101% | |
| Return on Common Equity | 0.15% | ◆ 13.22% | 10.35% | 6.88% | 10.35% -99% | |
| Return on Capital Employed | — | ◆ 13.89% | 7.84% | 11.63% | 11.63% | |
| Return on Assets | -0.15% | ◆ 7.01% | 5.56% | 5.22% | 5.56% -103% | |
| Credit & Quality | ||||||
| Total Debt/Equity | — | ◆ 0.01× | 0.55× | 0.07× | 0.07× | |
| Interest Coverage | -75.12× | ◆ 4.30× | 3.53× | 2.26× | 3.53× -2228% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹1,319 Cr | ₹310 Cr | ₹773 Cr | ₹999 Cr | ₹773 Cr +71% | |
| Net Income | −₹1.4 Cr | ₹31.4 Cr | ₹101 Cr | ₹76.8 Cr | ₹76.8 Cr -102% | |
| Total Assets | ₹936 Cr | ₹448 Cr | ₹1,824 Cr | ₹1,471 Cr | ₹1,471 Cr -36% | |
| EPS | ₹0.37 | ₹6.18 | ₹31.3 | ₹8.48 | ₹8.48 -96% | |
| Book Value per Share | ₹240.57 | ₹46.75 | ₹302.23 | ₹111.27 | ₹111.27 +116% | |